InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
5
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Noblett Karen, Directeur Médical. Officer active across 1 company, notably Axonics, Inc.. Cumulatively, 11 filings have been logged. Split: 0 buy · 5 sells. Total volume traded: €5m. Activity tracked since 31 January 2022. The latest transaction was filed on 15 November 2024 (Disposition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Noblett Karen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
34,428 shares@ US$71.0029.2% of flowCommon StockSEC:0001562180-24-007708:0
27,500 shares0Common StockSEC:0001562180-24-001013:0
15,999 shares@ US$69.001912.7% of flowCommon StockSEC:0001562180-24-000425:0
949 shares@ US$63.000.7% of flowCommon StockSEC:0001562180-23-008578:0
5,000 shares0Common StockSEC:0001562180-23-000872:0
18,519 shares@ US$14.193.3% of flowCommon StockSEC:0001562180-22-006777:0
13,964 shares@ US$25.824.5% of flowCommon StockSEC:0001562180-22-006777:1
32,483 shares@ US$78.157831.5% of flowCommon StockSEC:0001562180-22-006777:2
10,454 shares@ US$71.53199.4% of flowCommon StockSEC:0001562180-22-006605:0
13,531 shares@ US$57.2285100.0% of flowCommon StockSEC:0001562180-22-002872:0
5,350 shares0Common StockSEC:0001562180-22-001109:0
11 of 11 declarations
About Noblett Karen
Noblett Karen is the Chief Medical Officer at Axonics, Inc. In this role, she is responsible for the company's medical and clinical strategies, ensuring innovation and compliance in the healthcare sector.
